The “Mobile Autonomy for Children in End-stage Heart Failure” (MACH) project wins the 2020 Horizon Impact Award. This project was an international collaboration between RWTH Aachen University, Uniklinik RWTH Aachen, Newcastle upon Tyne Hospitals NHS...

Double interview with Prof. Dr. Christian Drosten, Director of the Institute of Virology at Charité Berlin and speaker at the World Health Summit, and Prof. Dr. Detlev Ganten, President and Founder of the World Health Summit.

Current findings on COVID-19, new global strategies for pandemic control and prevention, the role of Europe and the WHO in global health will be the core topics of this year's World Health Summit from October 25-27 in Berlin.

The past five years have contributed to intensive networking within the Healthcare Industry Cluster Berlin-Brandenburg. This has created the prerequisites for interdisciplinary, cross-sectoral and agile work on future topics and solutions for complex...

For many years, Berlin Heart has made a better future possible for children suffering from life-threatening heart diseases. In order to retain its innovative power and market leadership, the company currently invests around 40 percent of annual sales...

In recent months, there has been plenty of buzz generated around the Digitale Versorgung Gesetz (DVG), a new law promising a fast track to reimbursement of digital solutions within the German Statutory Healthcare System (SHI) -- and that buzz is for...

Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding....

CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.

The initiative is...

A group of researchers from Charité – Universitätsmedizin Berlin have further refined the use of deep brain stimulation in the treatment of obsessive-compulsive disorder. By accurately localizing electrode placement in the brains of patients, the...

Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), announced today the successful closing of a multi-million Euro financing round, following...